Archive for January, 2016

Another Day Another Anti-depressant

Thursday, January 28th, 2016

Another Day Another Anti-depressant

The New Year brings us another harmful psychoactive antidepressant – Brintellix (vortioxetine hydrobromide).

The mechanism of the antidepressant effect of vortioxetine is not understood, although it is theorized to be related to serotonin in the brain.

It has the same pattern of debilitating side effects as any other antidepressant, including addiction and suicidal thoughts and actions.

Developed by the Danish company H. Lundbeck A/S and marketed by Takeda Pharmaceuticals, it is an SSRI (selective serotonin reuptake inhibitor) drug. It was approved by the U.S. Food and Drug Administration in September, 2013. Its sales to date have not been inspiring, possibly related to its initial review by the National Institute for Health and Care Excellence (NICE) in the U.K. which said, “there was no convincing evidence to show that vortioxetine was any more or less effective than other antidepressants.”

Lundbeck and Takeda are making a new push to increase sales by submitting additional clinical trial data to the FDA and to NICE. You may now start seeing TV commercials for it. Don’t be fooled; there has been no change in the drug itself or its devastating withdrawal and side effects.

We must recognize that the real problem is that psychiatrists and other medical practitioners fraudulently diagnose life’s problems as an “illness” and stigmatize unwanted behavior as  “diseases.” Psychiatry’s stigmatizing labels, programs and treatments are harmful junk science; their diagnoses of “mental disorders” are a hoax – unscientific, fraudulent and harmful.

CCHR believes that everyone has the right to full informed consent.

FIND OUT! FIGHT BACK!

S.2388 Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2015

Saturday, January 16th, 2016

This bill, S.2388, introduced in the U.S. Senate by Senators Ted Cruz (R-TX) and Mike Lee (R-UT) on 12/10/2015, has been referred to the Committee on Health, Education, Labor, and Pensions (HELP).

Its stated purpose is “To amend the Federal Food, Drug, and Cosmetic Act to provide for reciprocal marketing approval of certain drugs, biological products, and devices that are authorized to be lawfully marketed abroad, and for other purposes.”

Essentially what this Act would provide is that if a drug, biological product, or device is approved for use in another country, then the U.S. Food and Drug Administration (FDA) would approve it for use in the United States without it having to go through the entire FDA approval process.

While we applaud the Senators for desiring to reduce the inherent bureaucracy of the FDA, we cannot help but notice that this would open the door for marketing various harmful psychiatric drugs and devices without satisfying the usual FDA requirements for safety and effectiveness.

The Act also authorizes an outreach campaign to encourage the sponsors of such products that are potentially eligible for reciprocal marketing approval to request such approval.

We think this Act deserves to be amended to explicitly exclude psychiatric drugs, and devices such as transcranial magnetic stimulation, vagus nerve stimulation, deep brain stimulation, or any other electric shock or magnetic wave device designed to interfere with the brain.

Please contact your U.S. Senator and the members of HELP to express your viewpoint regarding S.2388.

Victims of Brain Stimulation Abuse Urged to Report

Friday, January 1st, 2016

Victims of Brain Stimulation Abuse Urged to Report

CCHR Nashville, TN — Almost exactly two years ago on January 1, 2014, Scientific American magazine published an article on Deep Brain Stimulation, describing an experiment on a Dutch man wherein psychiatric researchers “…bored small holes in his skull and guided two long, thin probes deep into his head. The ends of the probes were lined with small electrodes… (psychiatrists) ran the connecting wires under his scalp, behind his ear and down to a battery pack sewn under the skin of his chest. Once turned on, the electrodes began delivering constant electrical pulses.”

In response to this alarming new therapy, the Citizens Commission of Human Rights of Nashville (CCHR Nashville) has called for victims to report abuse suffered during this or any other psychiatric treatment.

On the website cchrnashville.org, is the question: “Do you know someone who has been damaged by experimental psychiatric treatments including transcranial magnetic stimulation (TMS), vagus nerve stimulation (VNS), deep brain stimulation (DBS) or any other electric shock or magnetic wave to the brain?” Then follows a link to report abuse from these treatments.

CCHR has long been an advocate for human rights, especially as relates to patients’ rights in the field of mental health. Per the international CCHR website, cchr.org, “CCHR has long fought to restore basic inalienable human rights to the field of mental health, including, but not limited to, full informed consent regarding the medical legitimacy of psychiatric diagnosis, the risks of psychiatric treatments, the right to all available medical alternatives and the right to refuse any treatment considered harmful.”

Abuses from treatment may be reported online or by mail. The report form can be found at cchrnashville.org/report-abuse.

CCHR is a non-profit, non-political, non-religious mental health watchdog. Its mission is to eradicate abuses committed under the guise of mental health and enact patient and consumer protections. CCHR receives reports about abuses in the field of mental health and is especially interested in situations where persons experienced abuse or damage due to a false diagnosis or unwanted and harmful psychiatric treatments, such as psychiatric drugs, electroshock (ECT) and electronic or magnetic brain stimulation (TMS). CCHR is often able to assist with filing complaints, and can work with a person’s attorney to further investigate the case. To contact CCHR Nashville for more information, visit cchrnashville.org.